From the Division of Nephrology, David Geffen School of Medicine at the University of California, Los Angeles, and the Nephrology Section, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (C.M.R.), the Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine School of Medicine, Orange (C.M.R., K.K.-Z.), the Nephrology Section, Tibor Rubin Veterans Affairs Medical Center, Long Beach (K.K.-Z.), and the Division of Nephrology, Hypertension, and Transplantation, Lundquist Institute at Harbor-UCLA Medical Center, Torrance (K.K.-Z.) — all in California.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
